focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Jun 2022 15:19

RNS Number : 6815P
Barkby Group PLC
21 June 2022
 

21 June 2022

Barkby Group PLC

("Barkby" or the "Company")

Director/PDMR Shareholding

Barkby Group PLC was notified on 20 June 2022 that on the same day, Douglas Benzie, Chief Financial Officer of the Company, had transferred via sale and purchase (the "Transfer") 833,334 ordinary shares of £0.00860675675675676 each in the Company ("Ordinary Shares") from being held in his own name to being held in his self-invested personal pension ("SIPP").

Following the completion of the Transfer, there will be no change to Mr Benzie's total beneficial interest in the Company, being 833,334 Ordinary Shares representing approximately 0.58% of the Company's issued share capital.

Enquiries: 

Barkby Group plc

Charles Dickson (Executive Chairman)

Douglas Benzie (CFO)

 

via Camarco

finnCap Ltd (Nomad and Broker)

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)

 

+44 (0) 20 7220 0500

Camarco (Financial PR)

Jennifer Renwick/Phoebe Pugh

+44 (0) 20 3757 4994

 

Notes to editors 

About The Barkby Group Plc:

 

Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include: Barkby Real Estate, Barkby Pub Co. and Barkby Investments (comprising of Workshop Coffee, Centurian Automotive, Cambridge Sleep Sciences and a minority stake in Verso Biosense).

Barkby's strategy is to accelerate and maximise opportunities within its existing businesses.

 

The Notification of Dealing Forms set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Douglas Alexander Benzie

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Barkby Group plc

b)

LEI:

213800X57YXZVILB9E84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of £0.00860675675675676

GB00BL6TZZ70

b)

Nature of the transaction:

Transfer via sale and purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s) pence

Volume(s)

Sold

11.250

833,334

Purchased

11.254

833,334

d)

Aggregated information:

· Aggregated volume:

· Price:

 

N/A

e)

Date of the transaction:

20 June 2022

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKDBDQBKDAAB
12
Date   Source Headline
27th Oct 20219:05 amRNSSecond Price Monitoring Extn
27th Oct 20219:00 amRNSPrice Monitoring Extension
27th Oct 20217:00 amRNSTrading Statement and Property Acquisition
10th Aug 20217:00 amRNSTrading Statement
16th Jun 20217:00 amRNSNew lease for The Ebrington Arms
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
7th May 20211:48 pmRNSResult of AGM and change of name
30th Apr 20217:00 amRNSInterim Results
15th Apr 20217:00 amRNSCambridge Sleep Sciences signs new partners
9th Apr 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Apr 20217:00 amRNSVerso Biosense signs collaboration agreement
31st Mar 20216:29 pmRNSFinal Results
25th Mar 20217:00 amRNSVerso Biosense signs agreement with hospital
11th Mar 20217:00 amRNSCambridge Sleep Sciences partnership announcement
3rd Mar 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSExchange of Contracts at Malden, Essex
24th Dec 20207:00 amRNSExtension of Warrants
21st Dec 20207:00 amRNSExercise of Warrants and Total Voting Rights
6th Nov 20207:03 amRNSExtension of Reporting Deadline
30th Oct 20207:00 amRNSWorkshop Coffee becomes UK Distributor for MiiR
23rd Oct 20207:00 amRNSCambridge Sleep Sciences Ltd launches 'SleepHub™'
30th Sep 20207:00 amRNSCompany Update and Issue of Equity
17th Sep 20207:00 amRNSNew lease for The Harcourt Arms
10th Aug 20207:00 amRNSPractical Completion of Hastings
3rd Aug 20207:00 amRNSInvestment in VivoPlex Group
22nd Jul 20207:00 amRNSUpdate and CBILS loan
21st Apr 20207:00 amRNSAgreement with Cambridge Sound Technologies
20th Apr 20207:32 amRNSVivoPlex prepares for clinical feasibility study
24th Mar 20202:57 pmRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSConfirmation of Director Appointment
23rd Mar 20207:00 amRNSInterim Results
3rd Mar 20207:00 amRNSProposed acquisition
6th Feb 20207:00 amRNSAppointment of Senior Manager
3rd Feb 20207:00 amRNSAppointment of Chief Financial Officer
17th Jan 20207:00 amRNSExchange of Contracts at Huntingdon
7th Jan 20207:00 amRNSCompletion of Acquisition
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.